Treatment with FGF21 has been shown to improve glucose and lipid homeostasis, ameliorate hepatic steatosis [12], preserve β-cell functions [13], increase the number of brown adipocytes [14], and decrease atherosclerosis [15]. The gene discussed is FGF21; the disease is Hepatic steatosis.